Axinn Named a “Legal Lion” for Federal Circuit Patent Win
January 18, 2019
Axinn was named a “Legal Lion” in the Law360 Weekly Verdict roundup for its Federal Circuit win on behalf of Alvogen Pine Brook LLC. On January 14, 2019, the Federal Circuit upheld a lower court ruling that cleared Axinn’s client Alvogen of patent infringement. The decision affirmed Axinn’s trial court victory, in which a Delaware Federal District court ruled that Alvogen’s generic version of the colitis medication Uceris® did not infringe a patent owned by Cosmo Technologies Ltd. Alvogen was represented by Axinn partners Jason Murata, who argued the case before the Federal Circuit, and Matthew Becker, who tried the case before the Delaware District Court.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
American Investment Council’s General Counsel Day
Speaking Engagement
Antitrust
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
Biosimilar Approval Pathway Changes Sponsors Need to Monitor
Media Mentions
Intellectual Property

